South Korea · Delayed Price · Currency is KRW Bio Port Korea Statistics
Total Valuation
Bio Port Korea has a market cap or net worth of KRW 41.68 billion. The enterprise value is 30.54 billion.
| Market Cap | 41.68B |
| Enterprise Value | 30.54B |
Important Dates
The next estimated earnings date is Friday, November 14, 2025.
| Earnings Date | Nov 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Bio Port Korea has 4.43 million shares outstanding. The number of shares has increased by 28.24% in one year.
| Current Share Class | 4.43M |
| Shares Outstanding | 4.43M |
| Shares Change (YoY) | +28.24% |
| Shares Change (QoQ) | +6.37% |
| Owned by Insiders (%) | 50.36% |
| Owned by Institutions (%) | 0.48% |
| Float | 1.39M |
Valuation Ratios
The trailing PE ratio is 51.13 and the forward PE ratio is 5.81.
| PE Ratio | 51.13 |
| Forward PE | 5.81 |
| PS Ratio | 0.57 |
| PB Ratio | 1.08 |
| P/TBV Ratio | 1.09 |
| P/FCF Ratio | 6.16 |
| P/OCF Ratio | 5.55 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 5.68, with an EV/FCF ratio of 4.52.
| EV / Earnings | 47.41 |
| EV / Sales | 0.42 |
| EV / EBITDA | 5.68 |
| EV / EBIT | 9.45 |
| EV / FCF | 4.52 |
Financial Position
The company has a current ratio of 2.75, with a Debt / Equity ratio of 0.34.
| Current Ratio | 2.75 |
| Quick Ratio | 2.01 |
| Debt / Equity | 0.34 |
| Debt / EBITDA | 2.46 |
| Debt / FCF | 1.96 |
| Interest Coverage | 4.28 |
Financial Efficiency
Return on equity (ROE) is 2.38% and return on invested capital (ROIC) is 4.53%.
| Return on Equity (ROE) | 2.38% |
| Return on Assets (ROA) | 3.79% |
| Return on Invested Capital (ROIC) | 4.53% |
| Return on Capital Employed (ROCE) | 7.48% |
| Revenue Per Employee | 678.69M |
| Profits Per Employee | 6.02M |
| Employee Count | 107 |
| Asset Turnover | 1.36 |
| Inventory Turnover | 9.10 |
Taxes
| Income Tax | -32.09M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -37.87% in the last 52 weeks. The beta is -0.00, so Bio Port Korea's price volatility has been lower than the market average.
| Beta (5Y) | -0.00 |
| 52-Week Price Change | -37.87% |
| 50-Day Moving Average | 12,087.40 |
| 200-Day Moving Average | 14,270.78 |
| Relative Strength Index (RSI) | 25.72 |
| Average Volume (20 Days) | 44,005 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Bio Port Korea had revenue of KRW 72.62 billion and earned 644.23 million in profits. Earnings per share was 184.04.
| Revenue | 72.62B |
| Gross Profit | 19.99B |
| Operating Income | 3.23B |
| Pretax Income | 612.14M |
| Net Income | 644.23M |
| EBITDA | 5.38B |
| EBIT | 3.23B |
| Earnings Per Share (EPS) | 184.04 |
Balance Sheet
The company has 24.36 billion in cash and 13.23 billion in debt, giving a net cash position of 11.13 billion or 2,513.22 per share.
| Cash & Cash Equivalents | 24.36B |
| Total Debt | 13.23B |
| Net Cash | 11.13B |
| Net Cash Per Share | 2,513.22 |
| Equity (Book Value) | 38.43B |
| Book Value Per Share | 8,677.49 |
| Working Capital | 24.50B |
Cash Flow
In the last 12 months, operating cash flow was 7.51 billion and capital expenditures -744.12 million, giving a free cash flow of 6.76 billion.
| Operating Cash Flow | 7.51B |
| Capital Expenditures | -744.12M |
| Free Cash Flow | 6.76B |
| FCF Per Share | 1,527.25 |
Margins
Gross margin is 27.53%, with operating and profit margins of 4.45% and 0.89%.
| Gross Margin | 27.53% |
| Operating Margin | 4.45% |
| Pretax Margin | 0.84% |
| Profit Margin | 0.89% |
| EBITDA Margin | 7.40% |
| EBIT Margin | 4.45% |
| FCF Margin | 9.31% |
Dividends & Yields
Bio Port Korea does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -28.24% |
| Shareholder Yield | -28.24% |
| Earnings Yield | 1.55% |
| FCF Yield | 16.23% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on May 16, 2025. It was a reverse split with a ratio of 0.1486215.
| Last Split Date | May 16, 2025 |
| Split Type | Reverse |
| Split Ratio | 0.1486215 |
Scores
Bio Port Korea has an Altman Z-Score of 3.04 and a Piotroski F-Score of 6.
| Altman Z-Score | 3.04 |
| Piotroski F-Score | 6 |